Skip to main content
Richard Bram, MD, Pediatric Hematology & Oncology, Rochester, MN

RichardJBramMDPhD

Pediatric Hematology & Oncology Rochester, MN

Pediatric Coagulation Disorder Hematology, Pediatric Hematologic Oncology

Professor and Chair, Pediatric and Adolescent Medicine, Mayo Medical School

Dr. Bram is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bram's full profile

Already have an account?

  • Office

    200 1st St Sw
    Rochester, MN 55905
    Phone+1 507-284-2511

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1989 - 1993
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1987 - 1989
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - Present
  • MN State Medical License
    MN State Medical License 1998 - 2025
  • TN State Medical License
    TN State Medical License 1994 - 1999
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2002

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A New Mechanism for T-ALL Leukemogenesis: Early Expression of Alpha-Beta TCR Occurs in a Natural Subset of CD4-CD8- Double Negative (DN) Thymocytes Where MHC Engagemen...
    Richard J. Bram, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • A Golden Age for Pediatric Cardiology
    A Golden Age for Pediatric CardiologyFebruary 2nd, 2017

Grant Support

  • Cyclophilin B As A Therapeutic Target In GlioblastomaNational Institute Of Neurological Disorders And Stroke2011
  • CAML In T Cell Development And FunctionNational Institute Of Allergy And Infectious Diseases2008–2011
  • CAML In Normal And Oncogenic Functions Of The EGFRNational Cancer Institute2005–2009
  • Calcium Modulating Cyclophilin Ligand In Normal &Oncogenic Functions Of The EGFRNational Cancer Institute2007–2008
  • CAML In T Cell Development And FunctionNational Institute Of Allergy And Infectious Diseases2007
  • Role Of TACI In B Cell Function And TransformationNational Cancer Institute2004–2007
  • Role Of Cadml In Embryonic And Lymphocyte DevelopmentNational Cancer Institute2004
  • Role Of TACI In B Cell Function And TransformationNational Cancer Institute2003
  • Role Of Cadml In Embryonic And Lymphocyte DevelopmentNational Cancer Institute2000–2003
  • TACI And B Cell Function And TransformationNational Cancer Institute1999–2002
  • Core--Cell Microinjection Shared ResourceNational Cancer Institute1997–2002
  • TACI And B Cell Function And TransformationNational Cancer Institute1998